首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Corrigendum to 'Immunopathology in influenza virus infection: Uncoupling the friend from foe' [Clin. Immunol. 144 (2012) 57-69]
【24h】

Corrigendum to 'Immunopathology in influenza virus infection: Uncoupling the friend from foe' [Clin. Immunol. 144 (2012) 57-69]

机译:“流感病毒感染的免疫病理学:将朋友从仇敌中解脱出来”的勘误[临床。免疫144(2012)57-69]

获取原文
获取原文并翻译 | 示例
           

摘要

The prevalence and incidence of asthma have increased among obese children and adults, particularly among women. Obesity seems to be a predisposing factor for the development of asthma, but the underlying mechanisms of its influence are still uncertain. Various hypotheses have been proposed to explain the link between obesity and asthma such as a common genetic predisposition, developmental changes, altered lung mechanics, the presence of a systemic inflammatory process, and an increased prevalence of associated comorbid conditions. Over-diagnosis of asthma does not seem to be more frequent in obese compared to non-obese subjects, but the added effects of obesity on respiratory symptoms can affect asthma control assessment. Obesity can make asthma more difficult to control and is associated with a reduced beneficial effect of asthma medications. This could be due to a change in asthma phenotype, particularly evidenced as a less eosinophilic type of airway inflammation combined to the added effects of changes in lung mechanics. Weight loss is associated with a universal improvement of asthma and should be part of asthma management in the obese patient. Additional research should be conducted to better determine how obesity influences the development and clinical expression of asthma, establish the optimal management of asthma in this population and determine how obesity affects long-term asthma outcomes in these patients.
机译:肥胖儿童和成人,尤其是女性,哮喘的患病率和发病率有所增加。肥胖似乎是哮喘发展的诱因,但其影响的潜在机制仍不确定。提出了各种假设来解释肥胖与哮喘之间的联系,例如常见的遗传易感性,发育变化,肺力学改变,全身性炎症过程的存在以及相关合并症的患病率增加。与非肥胖受试者相比,肥胖的哮喘过度诊断似乎并不常见,但是肥胖对呼吸道症状的附加影响会影响哮喘控制评估。肥胖会使哮喘更加难以控制,并且与哮喘药物的有益作用降低有关。这可能是由于哮喘表型的改变,特别是由于气道炎症的嗜酸性程度较低而与肺力学改变的附加作用相结合。体重减轻与哮喘的普遍改善有关,应成为肥胖患者哮喘治疗的一部分。应该进行更多的研究,以更好地确定肥胖症如何影响哮喘的发展和临床表现,确定该人群中哮喘的最佳治疗方法,并确定肥胖症如何影响这些患者的长期哮喘结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号